Flovent Asthma Medicines Discontinued

The Family Asthma Act Aims to Expand Care for People with Asthma

The Elijah E. Cummings Family Asthma Act has been reintroduced to the House of Representatives. If passed, it would expand asthma programs to every state, Washington D.C., and Puerto Rico. Read our blog post about the bill and use our simple tool to contact your lawmakers to ask them to pass the Family Asthma Act.

AAFA fights for policies that would improve health outcomes and reduce health disparities for the asthma and allergy community, but we can’t do it alone. If you have already supported our efforts in 2023, thank you!

If you have not donated to AAFA yet this year, please consider making a gift today!

Together, we can ensure that everyone has access to the care they need to breathe easier.

DONATE TODAY

RESEARCH NEWS

New CDC Data on Long COVID; Updates on Treatments for Anaphylaxis, Atopic Dermatitis, EoE and Peanut Allergy; and Risks vs. Benefits in Asthma Care

Asthma

• Patients Prioritize Short-Term Improvements Over Long-Term Risks in Asthma Care
• Researchers Find Association Between Vaping and Asthma Among U.S. Teens

• Late-breaking Amlitelimab Phase 2b Data Presented at EADV Show Potential Best-in-Class Profile in Atopic Dermatitis

• New CDC Data on Long COVID-19
• Asthma Medicines Help Kids Who Test Positive for COVID-19
  [Editor’s note: This article includes a stock photo of a child using an inhaler improperly]

• Dupixent® (Dupilumab) sBLA for Treatment of Eosinophilic Esophagitis in Children Aged 1 to 11 Accepted for FDA Priority Review

• Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (Epinephrine) Sublingual Film
• Single and Repeat Dose Clinical Study of neffy® (Epinephrine Nasal Spray) Published in the Journal of Allergy and Clinical Immunology
• FDA Draft Guidance Could Result in Safer Food Options for People with Allergies to Sesame, Other Food Allergens
• Sublingual Immunotherapy May Result in Desensitization and Remission for Peanut-Allergic Children

CLINICAL TRIALS

Are You Currently Taking Oral Corticosteroids (OCS) for Your Asthma?

Would you like to contribute to important new research? SUNRISE is a clinical study investigating whether a new biologic treatment called tezepelumab may help to reduce or remove the need for OCS in adults with severe asthma. The study is looking for people who:

• Are between 18 and 80 years of age
• Have had an asthma diagnosis for at least 1 year
• Have been taking OCS for asthma for at least 6 months
• Have been using inhaled corticosteroids for at least a year, and a long-acting beta 2-agonist (LABA) for at least 3 months
• Have not been receiving any biologic treatment for asthma for at least 4 months
   

Now Accepting Patients for National Asthma Study

Are you a young adult between the ages of 18 and 30, African American or Black, with persistent asthma? Are you looking to get better control of your asthma? A national study is now accepting patients to test various mobile health programs. If you qualify for the study, you will be asked to use a mobile health program for about 10 weeks and complete four 30-minute questionnaires spread out over the course of one year. Everything is remote – you won’t have to come in for any study visits.

You will receive compensation for completing the study and will be given a Garmin physical activity tracker which you can keep after the study has ended.

Learn more about the study and see if you qualify.  

If you have any questions, please contact us at: 734-489-1949 or theathenaproject2022@gmail.com

INTERVIEWS AND FOCUS GROUPS

Research Opportunity: Caregivers for Children with Asthma

A Doctor of Nursing Practice (DNP) student at Regis College is recruiting for a project about caregivers and how well they cope with mental health symptoms while caring for a child with asthma. Your participation may help other caregivers like you. To be eligible, you must:

• Have a child of any age with a diagnosis of asthma who requires albuterol or steroid inhalers for management
• Be 18 years of age or older

You will be asked to complete a one-time, 15-minute survey about yourself and participate in a one-hour interview over Zoom in a group setting. You will be given a small reward at the completion of this project.

If you have any questions, please contact Timarra Warren by email or phone at: twar860@regiscollege.edu or 470-541-8440.
 

LEARN MORE

Now Recruiting Participants for Chronic Spontaneous Urticaria (CSU) Interviews

AAFA is looking for people who manage chronic spontaneous urticaria (CSU) to interview for a research project. The interview will provide an opportunity for you to share your firsthand experiences and needs when managing CSU. Collected feedback will help AAFA develop and improve our CSU resources.

The discussion should take about 30-45 minutes and can be scheduled at your convenience. If you are chosen to participate in an interview, we will provide compensation for your time. If you would like to participate in an interview, please take this quick survey to see if you are eligible.

LEARN MORE

Did You Miss Our Last Issue?

READ THE LATEST ISSUE

Thank you for your continued support.
Visit aafa.org, aafa.org/certified, kidswithfoodallergies.org